ECHO is proud to have a leading edge research team who provides patients with access to some of the most current clinical trials in the world. One of these trials is for unresectable locally advanced or metastatic colon cancer with […]
Read more »ECHO was pleased to be featured on Connecticut East This Week. Our Director of Research, Dr. Susan Johnson, shared the important role of clinical trials, while a patient shared her personal journey. Thank you to Brian Scott-Smith for allowing ECHO to share […]
Read more »Clinical trials help inform our understanding of cancer and improve prevention, diagnosis, treatment, and care.They play a significant role in the development of innovative and potentially life-saving therapies. There are many new exciting clinical trials on the horizon. Trials may be […]
Read more »Are you a healthy individual who would like to participate in a clinical trial to help identify biomarkers which may identify cancer at very early stages? Healthy is defined as at least 50 years old and never diagnosed with cancer. […]
Read more »The evERA Breast Cancer Study is looking for participants to help explore a promising study treatment for those whose breast cancer has returned or worsened, even after being treated with certain medicines and surgery. If this sounds like you or […]
Read more »Gritstone bio Inc., in collaboration with Worldwide Clinical Trials, is conducting a clinical trial of GRT C901/GRT-R902 (an investigational personalized vaccine) plus immunotherapy in patients with Advanced Stage IV Colorectal Cancer. Why is this study being done? The main purpose […]
Read more »If you have been diagnosed with muscle invasive bladder cancer, we are now offering a clinical trial for the general population. Please see the information below to learn more. If you are interested in participating in this clinical trial or […]
Read more »ECHO proudly enrolled the first patients in two genomic based studies ( MYTACTIC and KRYSTAL-7) opened within the OneOncology network. This demonstrates that innovative genomic testing affords patients the opportunity to be treated in their own community with personalized, targeted therapy. Below […]
Read more »Exact Sciences has identified ECHO as the highest enroller nationally for the cancer cohort for their Ascend 2 clinical trial. This primary endpoint of this trial is hopefully identifying biomarkers for early detection of cancer. ECHO is recruiting healthy individuals with no […]
Read more »
